Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
05/06/2004 | EP1414787A1 New derivatives of substituted anilines with herbicidal activity |
05/06/2004 | EP1414460A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
05/06/2004 | EP1307441B1 1,3-dioxolanes with antitussive activity |
05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
05/06/2004 | EP0960106B1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
05/06/2004 | CA2501438A1 Improvement in the storage stability of photoinitiators |
05/05/2004 | CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
05/05/2004 | CN1494528A Benzophenones as inhibitors of reverse transcriptase |
05/05/2004 | CN1494420A Compounds and compositions for delivering active agents |
05/05/2004 | CN1493568A Roxatiding bismuth citrate and its preparation method and use |
05/05/2004 | CN1493567A Methyl morpholine oxide dilute solution active carbon adsorption concentration purification method |
05/05/2004 | CN1148349C N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor |
05/05/2004 | CN1148346C Hydrazine derivs. |
05/04/2004 | US6730786 Process for the preparation of pyrazolopyrimidinones |
05/04/2004 | US6730784 As therapeutic agents for autoimmune diseases such as rheumatoid arthritis |
05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
05/04/2004 | US6730671 Compounds useful as reversible inhibitors of cathespin S |
04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
04/29/2004 | WO2004035534A2 Novel compounds having a dopaminergic and/or serotoninergic activity |
04/29/2004 | WO2004035525A1 Inhibitors of histone deacetylase |
04/29/2004 | WO2004035521A1 Bis-alkylbenzylamines |
04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
04/29/2004 | WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses |
04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
04/29/2004 | WO2002102787A3 Novel sulfonic acid derivatives |
04/29/2004 | WO2002083842A9 Small molecule inhibitors of secretion of proteins encoded by are-mrnas |
04/29/2004 | US20040083447 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands |
04/29/2004 | US20040082786 Piperazine based inhibitors of factor xa |
04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
04/29/2004 | US20040082642 Novel estrogen receptor ligands and method III |
04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
04/29/2004 | US20040082625 Osteoporosis, bone disorders |
04/29/2004 | US20040082617 Sulphones which modulate the action of gamma secretase |
04/29/2004 | US20040082595 Antiproliferative agents; antitumor agents; cyclin-dependent kinase inhibitor |
04/29/2004 | US20040082569 Novel substituted amides, their preparation and use |
04/29/2004 | US20040082547 Prevent thrombosis; anticholesterol agents; cardiovascular disorders; anticancer agents |
04/29/2004 | US20040081620 Measurement anticoagulant |
04/29/2004 | DE10248925A1 Neue Verbindungen mit dopaminerger und/oder serotoninerger Aktivität New connections with dopaminergic and / or serotonergic activity |
04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
04/28/2004 | EP1413307A1 Therapeutically active levorotatory and dextrorotatory 1-(4-chlorophenyl)phenylmethyl piperazines |
04/28/2004 | EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
04/28/2004 | EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
04/28/2004 | EP1412321A2 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids |
04/28/2004 | EP1412082A1 Method for hydrogenating organic compounds by means of ru/sio2 catalysts |
04/28/2004 | EP1411922A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
04/28/2004 | EP1294682B1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
04/28/2004 | EP1200384B1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
04/28/2004 | CN1147483C Adamantane derivatives |
04/28/2004 | CN1147294C Pentafluorobenzenesulfonamides and analogs |
04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
04/22/2004 | WO2004033441A1 Antibacterial agents |
04/22/2004 | WO2004033426A2 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
04/22/2004 | WO2004033415A1 Nitroaniline-based alkylating agents and their use as prodrugs |
04/22/2004 | WO2004032930A1 Method of treatment for cancer |
04/22/2004 | WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases |
04/22/2004 | WO2002094794A8 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
04/22/2004 | WO2000061134A9 Antimicrobial agents |
04/22/2004 | US20040077867 Amine compounds, their production and use |
04/22/2004 | US20040077861 Asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary |
04/22/2004 | US20040077857 Method of producting n-substituted 2,6-dialkyl morpholines |
04/22/2004 | US20040077729 2-,N-(Diphenyl)-propionamide derivatives as anticoagulants |
04/22/2004 | US20040077716 Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |
04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
04/22/2004 | US20040077502 Stable ethylene inhibiting compounds and methods for their preparation |
04/22/2004 | US20040074016 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing |
04/21/2004 | EP1411049A1 Estrogen Agonists/Antagonists |
04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
04/21/2004 | EP1409467A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
04/21/2004 | EP1409080A1 Medicament inhibiting sodium/calcium exchange system |
04/21/2004 | EP1408986A2 Proteomimetic compounds and methods |
04/21/2004 | EP1296946B1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
04/21/2004 | CN1490315A Synthesis of roxatidine acetate |
04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
04/21/2004 | CN1146536C Cycloethylene derivatives |
04/20/2004 | USRE38506 Potent inducers of terminal differentiation and methods of use thereof |
04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
04/20/2004 | US6723730 Capsaicin receptor ligands |
04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
04/20/2004 | US6723717 Sulfur-containing thyroxane derivatives and their use as hair growth promotors |
04/20/2004 | CA2215585C Practical synthesis of urea derivatives |
04/20/2004 | CA2060580C Ammonium salt of an alkenylsuccinic half-amide and the use thereof as corrosion inhibitor in oil and/or gas production technology |
04/15/2004 | WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors |